To determine whether NRF2 promotes the proliferative activity and differentiation capacity of osteoblasts under high glucose conditions by remitting ferroptosis, we added the T2DM + MaR1 + Erastin group, Erastin being a promoter of ferroptosis. Here, NFE2L2 is linked to type 2 diabetes mellitus.